NEW: Clinical ink Announces Strategic Investment LEARN MORE

McKesson Ventures
  • Portfolio
  • News & Insights
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Merck Digital Sciences Studio’s SciMar ONE is already demonstrating early value

by McKesson Ventures | Jun 29, 2023 | Media Coverage, Portfolio News

Last year, McKesson Ventures joined a group of funders including Merck, Microsoft, the Global Health Innovation Fund, Northpond Ventures, and the New Jersey Institute of Technology to bring to life a “founder-friendly” startup accelerator for companies in the...

Recent Posts

  • Clinical ink Announces Strategic Investment from Ardan Equity and GI Partners to Accelerate Next Phase of Growth
  • Latent Expands AI Platform to Unlock Access to a New Generation of Medicines
  • Komodo Health Wins 2026 Fierce AI Innovation Award for Commercial Strategy & Launch from Fierce Pharma
  • Silver and LYNX Launch Production AI Claims Automation to Help TPAs Modernize Claims Processing
  • HarmonyCares Ranks Among Medicare’s Top ACO REACH Performers for 2024
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

IN THE NEWS

ABOUT US

CONTACT US

  • Follow
©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings